EssilorLuxottica stock (FR0000121667): dividend option confirmed as investors assess valuation metrics

EssilorLuxottica shares in Paris trade below last year’s highs as investors digest the group’s latest dividend option approved at the 2026 AGM and reassess key valuation metrics such as earnings multiples and yield.

EssilorLuxottica shares were trading moderately lower on Euronext Paris on 06/05/2026, with the stock quoted around the mid-EUR 140s in recent afternoon trading, as investors digested the group’s latest dividend developments and reassessed its valuation following a strong run-up in 2025, according to data from Euronext as of 06/05/2026.

The France-based eyewear and lens manufacturer remains a heavyweight in the domestic equity market with its primary listing on Euronext Paris under the ticker EL, and the recent combination of dividend news and shifting sentiment around AI-enabled eyewear has kept the name in focus for local and international investors, according to Reuters coverage dated 06/03/2026.

At the company’s Annual General Meeting held in Paris, EssilorLuxottica’s shareholders approved a dividend option structure for the 2025 financial year, giving investors the choice between cash and shares, as reported by Vision Monday on 06/03/2026 and referencing a Reuters dispatch published the same day.Vision Monday / Reuters as of 06/03/2026

According to that report, the AGM decision followed a year of solid revenue growth in the company’s core prescription lenses, frames, and sunglasses activities, and the flexible dividend option is intended to balance cash returns with potential equity reinforcement.Reuters as of 06/03/2026

As of: 06/05/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: EssilorLuxottica
• Sector/industry: Eyewear, lenses, and optical retail
• Headquarters/country: Paris, France
• Core markets: Europe, North America, Asia-Pacific
• Key revenue drivers: Prescription lenses, optical frames, sunglasses, and retail optical chains
• Home exchange/listing venue: Euronext Paris (EL)
• Trading currency: EUR

EssilorLuxottica: core business model

EssilorLuxottica operates an integrated model that combines lens manufacturing, branded eyewear, and global optical retail networks, generating most of its revenue from prescription lenses and premium frames sold through both third-party opticians and its own stores.

Valuation metrics and multiples for EssilorLuxottica

On 06/05/2026, EssilorLuxottica’s share price around the mid-EUR 140s implied a market capitalization in the tens of billions of euros and placed the stock on a forward price-to-earnings multiple broadly in the low- to mid-20s based on consensus forecasts compiled by MarketScreener as of 05/30/2026, situating the group at a premium to many traditional consumer-discretionary names but closer to other branded luxury and healthcare-exposed peers.MarketScreener as of 05/30/2026

MarketScreener’s data as of 05/30/2026 also indicate that EssilorLuxottica’s enterprise-value-to-EBITDA ratio stands in the mid-teens on a forward basis, while the dividend yield implied by the 2025 payout and current share price is in the low-2-percent range, underlining that investors are paying for the group’s brand strength, scale advantages, and exposure to structural demand for vision correction.MarketScreener as of 05/30/2026

Valuation discussions have also been influenced by the share’s trajectory since late 2025, when EssilorLuxottica benefited from enthusiasm around AI-enabled eyewear before retracing part of those gains; according to analysis by Ainvest on 06/02/2026, the stock has fallen roughly 22 percent from an all-time high of EUR 181.45 reached in November 2025 as that AI-glasses euphoria faded, prompting a closer look at underlying fundamentals rather than thematic momentum.Ainvest as of 06/02/2026

For income-focused shareholders, the AGM-approved dividend option for the 2025 year, described by Vision Monday and Reuters on 06/03/2026, effectively translates into a choice between immediate cash returns and additional equity exposure, which in turn interacts with the yield calculation and may influence how investors view the risk-reward profile at current valuation levels.

In the context of France’s equity market, EssilorLuxottica’s valuation is often compared with large-cap consumer and luxury groups, and the combination of its recurring vision-care demand, premium brands, and exposure to demographic trends such as aging populations helps explain why the stock can command higher multiples than many general retail or industrial names.

Conclusion

The latest AGM decision giving EssilorLuxottica shareholders a choice between cash and stock for the 2025 dividend comes as the Paris-listed shares trade below their late-2025 peak and valuation multiples remain above many traditional consumer names.

With forward P/E and EV/EBITDA metrics in the low- to mid-range of the premium consumer and healthcare space, as indicated by MarketScreener on 05/30/2026, investors appear to be weighing the group’s structural growth drivers and brand strength against the normalization of AI-glasses enthusiasm and the implications of the flexible dividend policy at current price levels.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.